ResearchSafe

Hims & Hers to offer generic semaglutide in Canada

Posted by formererin in Weight Loss & Metabolic - 1 points, 0 comments.

https://www.mobihealthnews.com/news/hims-hers-launches-generic-semaglutide-offering-canada

The piece reports that Hims & Hers will launch a generic version of semaglutide in Canada after Novo Nordisk let’ s patents lapse by skipping a upkeep fee. The company claims the drug will be cheaper and more accessible for people looking to use GLP‑1 therapy for weight loss. Fwiw, it’s a neat story about price competition, not a clinical trial.

I’m not surprised that a big telehealth brand is jumping on the generic bandwagon. The real question is whether the pricing boon will translate into more patients sticking with the therapy, or just a flood of people trying the drug for a few weeks before dropping it for side‑effects or the “just a little more weight” plateau. In my own protocol, semaglutide tends to work best when the dose is titrated slowly; if you can slash the cost, maybe more people can afford the slower ramp. But cost isn’t the only barrier; insurance coverage, physician oversight, and the need to monitor blood glucose in people with pre‑diabetes remain hurdles.

Will the generic price drop make GLP‑1s a mainstream weight‑loss tool, or will the shift only modestly improve access while keeping the usual compliance challenges?

Community discussion - research and educational context only. Not medical advice.